These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 15861202

  • 1. Neonatal Gaucher disease presenting as persistent thrombocytopenia.
    Roth P, Sklower Brooks S, Potaznik D, Cooma R, Sahdev S.
    J Perinatol; 2005 May; 25(5):356-8. PubMed ID: 15861202
    [Abstract] [Full Text] [Related]

  • 2. Clinical consequences of interrupting enzyme replacement therapy in children with type 1 Gaucher disease.
    Drelichman G, Ponce E, Basack N, Freigeiro D, Aversa L, Graciela E, Kohan R.
    J Pediatr; 2007 Aug; 151(2):197-201. PubMed ID: 17643778
    [Abstract] [Full Text] [Related]

  • 3. [Gaucher disease type I diagnosed at 63 years old presenting with thrombocytopenia].
    Kawahara S, Kato A, Oshimi K, Ida H.
    Rinsho Ketsueki; 2008 May; 49(5):335-9. PubMed ID: 18572811
    [Abstract] [Full Text] [Related]

  • 4. [Presenting signs and symptoms in Gaucher disease].
    Erdös M, Tóth J, Maródi L.
    Orv Hetil; 2002 Oct 13; 143(41):2327-35. PubMed ID: 12434734
    [Abstract] [Full Text] [Related]

  • 5. Perinatal lethal Gaucher disease: a distinct phenotype along the neuronopathic continuum.
    Eblan MJ, Goker-Alpan O, Sidransky E.
    Fetal Pediatr Pathol; 2005 Oct 13; 24(4-5):205-22. PubMed ID: 16396828
    [Abstract] [Full Text] [Related]

  • 6. Reversal of portal hypertension in a patient with primary biliary cirrhosis: disappearance of esophageal varices and thrombocytopenia.
    El-Husseini R, Kaplan MM.
    Am J Gastroenterol; 2004 Sep 13; 99(9):1859-60. PubMed ID: 15330929
    [No Abstract] [Full Text] [Related]

  • 7. Parallel randomized trials of risk-based therapy for fetal alloimmune thrombocytopenia.
    Berkowitz RL, Kolb EA, McFarland JG, Wissert M, Primani A, Lesser M, Bussel JB.
    Obstet Gynecol; 2006 Jan 13; 107(1):91-6. PubMed ID: 16394045
    [Abstract] [Full Text] [Related]

  • 8. The clinical and demographic characteristics of nonneuronopathic Gaucher disease in 887 children at diagnosis.
    Kaplan P, Andersson HC, Kacena KA, Yee JD.
    Arch Pediatr Adolesc Med; 2006 Jun 13; 160(6):603-8. PubMed ID: 16754822
    [Abstract] [Full Text] [Related]

  • 9. Congenital Gaucher disease with nonimmune hydrops/erythroblastosis, infantile arterial calcification, and neonatal hepatitis/fibrosis. Clinicopathologic report with enzymatic and genetic analysis.
    Spear GS, Beutler E, Hungs M.
    Fetal Pediatr Pathol; 2007 Jun 13; 26(3):153-68. PubMed ID: 17886025
    [Abstract] [Full Text] [Related]

  • 10. Clinical and enzyme studies in Gaucher disease.
    Kaur M, Kabra M, Kher A, Naik G, Bharucha BA, Verma IC.
    Indian Pediatr; 1996 Sep 13; 33(9):735-8. PubMed ID: 9057400
    [Abstract] [Full Text] [Related]

  • 11. Non-neuronopathic Gaucher disease due to saposin C deficiency.
    Tylki-Szymańska A, Czartoryska B, Vanier MT, Poorthuis BJ, Groener JA, Ługowska A, Millat G, Vaccaro AM, Jurkiewicz E.
    Clin Genet; 2007 Dec 13; 72(6):538-42. PubMed ID: 17919309
    [Abstract] [Full Text] [Related]

  • 12. [Gaucher disease].
    Timonen T, Möttönen M, Nousiainen T, Herva R, Savolainen ER.
    Duodecim; 2005 Dec 13; 121(19):2068-76. PubMed ID: 16300295
    [No Abstract] [Full Text] [Related]

  • 13. An open-label, noncomparative study of miglustat in type I Gaucher disease: efficacy and tolerability over 24 months of treatment.
    Pastores GM, Barnett NL, Kolodny EH.
    Clin Ther; 2005 Aug 13; 27(8):1215-27. PubMed ID: 16199246
    [Abstract] [Full Text] [Related]

  • 14. Use of fluorescent substrates for characterization of Gaucher disease mutations.
    Ron I, Dagan A, Gatt S, Pasmanik-Chor M, Horowitz M.
    Blood Cells Mol Dis; 2005 Aug 13; 35(1):57-65. PubMed ID: 15916907
    [Abstract] [Full Text] [Related]

  • 15. Gaucher disease: progressive mesenteric and mediastinal lymphadenopathy despite enzyme therapy.
    Burrow TA, Cohen MB, Bokulic R, Deutsch G, Choudhary A, Falcone RA, Grabowski GA.
    J Pediatr; 2007 Feb 13; 150(2):202-6. PubMed ID: 17236903
    [Abstract] [Full Text] [Related]

  • 16. Treatment of severe cholestasis in neonatal Dubin-Johnson syndrome with ursodeoxycholic acid.
    Regev RH, Stolar O, Raz A, Dolfin T.
    J Perinat Med; 2002 Feb 13; 30(2):185-7. PubMed ID: 12012642
    [Abstract] [Full Text] [Related]

  • 17. Perinatal lethal phenotype with generalized ichthyosis in a type 2 Gaucher disease patient with the [L444P;E326K]/P182L genotype: effect of the E326K change in neonatal and classic forms of the disease.
    Chabás A, Gort L, Díaz-Font A, Montfort M, Santamaría R, Cidrás M, Grinberg D, Vilageliu L.
    Blood Cells Mol Dis; 2005 Feb 13; 35(2):253-8. PubMed ID: 15967693
    [Abstract] [Full Text] [Related]

  • 18. [Gaucher Disease type 1 mimicking immune thrombocytopenia: Role of hyperferritinemia and hypergammaglobulinemia in the initial evaluation of an isolated thrombopenia].
    Faucher B, Seguier J, Swiader L, Cuquemelle C, Cerutti D, Ebbo M.
    Rev Med Interne; 2019 Oct 13; 40(10):680-683. PubMed ID: 31213336
    [Abstract] [Full Text] [Related]

  • 19. Addison's disease and hypothyroidism untreated until twenty-four weeks of pregnancy.
    Scrimin F, Panerari F, Guaschino S.
    Acta Obstet Gynecol Scand; 2005 Feb 13; 84(2):198-9. PubMed ID: 15683384
    [No Abstract] [Full Text] [Related]

  • 20. Selectively high levels of serum interleukin 17 in a newborn infant with progressive severe cholestasis.
    Ichikawa M, Takahashi N, Yada Y, Koike Y, Kawamata R, Kono Y, Honma Y, Yotsumoto S, Momoi MY.
    Pediatrics; 2010 Jul 13; 126(1):e247-50. PubMed ID: 20547643
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.